Kodiak Sciences Inc. (KOD) saw its stock price soar 5.66% during intraday trading on Monday, following positive analyst actions.
The surge comes after Chardan Capital upgraded the stock to Buy from Neutral and significantly raised its price target to $61 from $14. According to analysts polled by FactSet, Kodiak Sciences has an average rating of Buy with a mean price target of $63.33, reflecting growing optimism about the company's prospects.
Such analyst upgrades often signal improved confidence in a company's future performance, potentially driving investor interest and stock price appreciation.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments